标题
The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
作者
关键词
-
出版物
Cancers
Volume 10, Issue 12, Pages 474
出版商
MDPI AG
发表日期
2018-11-30
DOI
10.3390/cancers10120474
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
- (2018) Hirokazu Sadahiro et al. CANCER RESEARCH
- Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
- (2018) Eric Ubil et al. JOURNAL OF CLINICAL INVESTIGATION
- Abstract 2488: Functional characterization of nuclear TYRO3 in colorectal cancer
- (2018) Shaw-Jenq Tsai et al. CANCER RESEARCH
- MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression
- (2018) Ancheng Qin et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group
- (2018) Jichen Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- The TAM receptor Tyro3 regulates myelination in the central nervous system
- (2017) Rainer Akkermann et al. GLIA
- Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms
- (2017) Peter P. Ruvolo et al. HAEMATOLOGICA
- A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma
- (2017) Tasnuva D. Kabir et al. HEPATOLOGY
- Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
- (2017) Canan Kasikara et al. MOLECULAR CANCER RESEARCH
- Cell signalling pathway regulation by RanBPM: molecular insights and disease implications
- (2017) Louisa M. Salemi et al. Open Biology
- Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms
- (2017) Peter P. Ruvolo et al. HAEMATOLOGICA
- The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
- (2017) Dou-Sheng Bai et al. Scientific Reports
- Abstract 1265: Dysregulated tyrosine kinase Tyro3 signaling in acute myeloid leukemia
- (2016) Fatma Eryildiz et al. CANCER RESEARCH
- RXDX-106 Is an orally-available, potent and selective TAM/MET inhibitor demonstrating preclinical efficacy in MET-dependent human malignancies
- (2016) A. Franovic et al. EUROPEAN JOURNAL OF CANCER
- Hetero-interaction amongst Tyro3 and Axl receptor tyrosine kinases diversifies cancer signalling
- (2016) M. Vouri et al. EUROPEAN JOURNAL OF CANCER
- Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer
- (2016) Peter B. Alexander et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of TYRO3/Akt signaling participates in hypoxic injury in hippocampal neurons
- (2016) Yan-zhen Zhu et al. Neural Regeneration Research
- Targeting TYRO3 inhibits epithelial–mesenchymal transition and increases drug sensitivity in colon cancer
- (2016) C-W Chien et al. ONCOGENE
- The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity
- (2016) P. Y. Chan et al. SCIENCE
- Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors
- (2016) Xiaodong Wang et al. ACS Medicinal Chemistry Letters
- TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
- (2016) Robin Schmitz et al. Oncotarget
- Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
- (2016) Viralkumar Davra et al. Cancers
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors
- (2015) S. Sinha et al. CLINICAL CANCER RESEARCH
- Metformin targets Axl and Tyro3 receptor tyrosine kinases to inhibit cell proliferation and overcome chemoresistance in ovarian cancer cells
- (2015) NAM-YI KIM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression
- (2015) YAN DUAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination
- (2015) Yuki Miyamoto et al. MOLECULAR BIOLOGY OF THE CELL
- The Role and Regulation of Osteoclasts in Normal Bone Homeostasis and in Response to Injury
- (2015) Adrian McArdle et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
- (2015) Alisa B. Lee-Sherick et al. Oncotarget
- Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma
- (2015) Parag P. Patwardhan et al. Oncotarget
- Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells
- (2015) CHUHEE LEE Molecular Medicine Reports
- TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
- (2014) J. H. M. van der Meer et al. BLOOD
- The Role of Snail in EMT and Tumorigenesis
- (2014) Yifan Wang et al. CURRENT CANCER DRUG TARGETS
- Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells
- (2014) YOUNG-AH SUH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
- (2014) Wen-I Tsou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
- (2014) Weihe Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis
- (2013) Gisela Ruiz-Heiland et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines
- (2013) Stephen J. Demarest et al. BIOCHEMISTRY
- TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system
- (2013) Angela M. Pierce et al. BRAIN RESEARCH
- Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer
- (2013) Lutfi Suleiman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- UNC1062, a new and potent Mer inhibitor
- (2013) Jing Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MERTK receptor tyrosine kinase is a therapeutic target in melanoma
- (2013) Jennifer Schlegel et al. JOURNAL OF CLINICAL INVESTIGATION
- Whole-exome sequencing of pancreatic neoplasms with acinar differentiation
- (2013) Yuchen Jiao et al. JOURNAL OF PATHOLOGY
- UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic LeukemiaIn VitroandIn Vivo
- (2013) Sandra Christoph et al. MOLECULAR CANCER THERAPEUTICS
- Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
- (2013) S Ammoun et al. ONCOGENE
- GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
- (2013) Russell S. Taichman et al. PLoS One
- Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas
- (2013) Hiba el Sayadi et al. Targeted Oncology
- Biological Function of Nuclear Receptor Tyrosine Kinase Action
- (2013) S. Song et al. Cold Spring Harbor Perspectives in Biology
- Biology of the TAM Receptors
- (2013) G. Lemke Cold Spring Harbor Perspectives in Biology
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression
- (2012) Yoshihiro Higuchi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase
- (2012) Noel A. Powell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase
- (2012) Noel A. Powell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
- (2012) S. Betty Yan et al. INVESTIGATIONAL NEW DRUGS
- Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons
- (2012) Prashant Kumar Modi et al. MOLECULAR BIOLOGY OF THE CELL
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
- (2012) R M A Linger et al. ONCOGENE
- Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
- (2012) Jessica E. Brown et al. PLoS One
- Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
- (2012) Jing Liu et al. ACS Medicinal Chemistry Letters
- Novel and selective spiroindoline-based inhibitors of sky kinase
- (2011) Noel A. Powell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
- (2011) E. Avilla et al. CANCER RESEARCH
- Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands
- (2011) Thomas Schmidt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Type 2 innate immune responses and the natural helper cell
- (2011) Shigeo Koyasu et al. IMMUNOLOGY
- Galectin-3 is a new MerTK-specific eat-me signal
- (2011) Nora B. Caberoy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase
- (2011) Marialuisa Sensi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Profiling of Antibody Production against Xenograft-released Proteins by Protein Microarrays Discovers Prostate Cancer Markers
- (2011) Flip H. Jansen et al. JOURNAL OF PROTEOME RESEARCH
- Hypothalamic but not pituitary or ovarian defects underlie the reproductive abnormalities in Axl/Tyro3 null mice
- (2011) Angela Pierce et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma
- (2011) K. Tworkoski et al. MOLECULAR CANCER RESEARCH
- Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway
- (2011) Huang Guo et al. Molecular Neurodegeneration
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Receptor tyrosine kinases and their activation in melanoma
- (2011) David J. Easty et al. Pigment Cell & Melanoma Research
- Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor
- (2010) D. Zhu et al. BLOOD
- Autoimmunity and the Clearance of Dead Cells
- (2010) Shigekazu Nagata et al. CELL
- A systems view of epithelial–mesenchymal transition signaling states
- (2010) Stuart Thomson et al. CLINICAL & EXPERIMENTAL METASTASIS
- Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis
- (2010) Nora B Caberoy et al. EMBO JOURNAL
- Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
- (2010) Rachel MA Linger et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Protein S Protects Neurons from Excitotoxic Injury by Activating the TAM Receptor Tyro3-Phosphatidylinositol 3-Kinase-Akt Pathway through Its Sex Hormone-Binding Globulin-Like Region
- (2010) Z. Zhong et al. JOURNAL OF NEUROSCIENCE
- The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer
- (2010) Shannon Otsuka et al. Journal of Thoracic Oncology
- Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization
- (2010) J. M. E. M. COSEMANS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma
- (2010) S. Ammoun et al. NEURO-ONCOLOGY
- Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
- (2009) S. Loges et al. BLOOD
- Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
- (2009) L. Liu et al. CANCER RESEARCH
- GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche
- (2009) Yusuke Shiozawa et al. EXPERIMENTAL HEMATOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery ofN-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily
- (2009) Gretchen M. Schroeder et al. JOURNAL OF MEDICINAL CHEMISTRY
- A genomic screen identifies TYRO3 as a MITF regulator in melanoma
- (2009) S. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NGF-induced Tyro3 and Axl function as survival factors for differentiating PC12 cells
- (2008) Yan Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
- (2008) M. M. Loriaux et al. BLOOD
- AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
- (2008) Y.-X. Zhang et al. CANCER RESEARCH
- Structural insights into the inhibited states of the Mer receptor tyrosine kinase
- (2008) Xudong Huang et al. JOURNAL OF STRUCTURAL BIOLOGY
- Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
- (2008) L L Remsing Rix et al. LEUKEMIA
- Axl and Tyro3 Modulate Female Reproduction by Influencing Gonadotropin-Releasing Hormone Neuron Survival and Migration
- (2008) Angela Pierce et al. MOLECULAR ENDOCRINOLOGY
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started